DBV Technologies S.A. (DBVT)
NASDAQ·Healthcare·Biotechnology
$20.76
+1.81%
Mkt Cap $473.65M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | $1.45M | $574.60K | -60.47% | -$1.30 | -$1.15 | +11.54% | — | — |
| Q4 2025 Oct 28, 2025 | $1.06M | $3.23M | +204.48% | -$1.45 | -$1.20 | +17.24% | — | — |
| Q3 2025 Jul 29, 2025 | $756.53K | $1.74M | +129.58% | -$0.21 | -$1.55 | -638.10% | — | — |
| Q2 2025 Apr 30, 2025 | $500.00K | $906.41K | +81.28% | -$0.24 | -$0.26 | -8.33% | — | — |
| Q1 2025 Mar 27, 2025 | $462.75K | $553.10K | +19.52% | -$2.00 | -$1.20 | +40.00% | — | — |
| Q4 2024 Nov 6, 2024 | $1.04M | $1.18M | +13.01% | -$1.90 | -$0.80 | +57.89% | — | — |
| Q3 2024 Jul 30, 2024 | $1.14M | $1.25M | +9.50% | -$1.30 | -$1.70 | -30.77% | — | — |
| Q2 2024 May 7, 2024 | $1.38M | $1.51M | +9.53% | -$2.20 | -$1.40 | +36.36% | — | — |
| Q1 2024 Mar 7, 2024 | $2.56M | $2.44M | -4.61% | -$0.32 | -$0.12 | +62.50% | — | — |
| Q4 2023 Oct 31, 2023 | $2.76M | $2.53M | -8.33% | -$0.30 | -$0.18 | +40.00% | — | — |
| Q3 2023 Jul 31, 2023 | $1.99M | $2.50M | +25.27% | -$0.26 | -$0.26 | +0.00% | — | — |
| Q2 2023 May 4, 2023 | $2.64M | $2.39M | -9.55% | -$0.50 | -$0.22 | +56.00% | — | — |
| Q1 2023 Mar 2, 2023 | $1.50M | -$1.40M | -193.34% | -$2.30 | -$2.30 | +0.00% | — | — |
| Q4 2022 Nov 3, 2022 | $2.51M | $2.03M | -19.17% | -$0.32 | -$0.18 | +43.75% | — | — |
| Q3 2022 Aug 1, 2022 | $1.71M | $1.60M | -6.22% | -$1.70 | -$1.80 | -5.88% | — | — |
| Q2 2022 May 2, 2022 | $2.50M | $2.82M | +12.48% | -$4.70 | -$1.50 | +68.09% | — | — |
| Q1 2022 Mar 3, 2022 | $2.42M | $2.59M | +7.07% | -$0.64 | -$0.26 | +59.38% | — | — |
| Q4 2021 Oct 26, 2021 | $2.56M | $1.54M | -39.94% | -$2.90 | -$2.20 | +24.14% | — | — |
| Q3 2021 Aug 2, 2021 | — | $1.77M | — | -$6.40 | -$2.80 | +56.25% | — | — |
| Q2 2021 May 3, 2021 | — | $3.46M | — | -$3.90 | -$2.70 | +30.77% | — | — |